Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks.
Gil YosipovitchPeter LioFranz J LegatRaj ChovatiyaMette DeleuranEvangeline PierceMarta CasillasYuxin DingFan E YangLaia BardoletSonja StänderPublished in: Dermatology and therapy (2024)
ADvocate1 (NCT04146363) and ADvocate2 (NCT04178967).